Yokoyama J, Ohba S, Fujimaki M, Anzai T, Kojima M, Ikeda K, Suzuki M, Yoshimoto H, Inoue K
Department of Otolaryngology, Head and Neck Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
Br J Cancer. 2014 Dec 9;111(12):2229-34. doi: 10.1038/bjc.2014.501. Epub 2014 Sep 25.
The most significant problem of intra-arterial chemotherapy for advanced paranasal sinus carcinomas and residual cancers supplied by internal carotid artery (ICA) and involving the skull base is the lack of salvage therapies.
The objective of the study was to evaluate the usefulness of intra-arterial chemotherapy including ICA infusion for treating advanced paranasal sinus carcinomas, which have invaded the skull base.
Forty-six patients with advanced paranasal sinus carcinomas supplied by ICA were treated by intra-arterial chemotherapy using CDDP and sodium thiosulphate (STS) as a neutraliser of CDDP toxicity. After evaluating CT angiography, 150 mg m(-2) of CDDP was superselectively administered weekly to each feeding artery including ICA four times.
The 10-year overall survival rate and progression-free survival rate were 70.7 and 60.2%, respectively. Compared with control group without infusing ICA, recurrences at anterior skullbase or anterior ethomoid sinus were significantly diminished. Of 32 patients in which the orbital apex had been invaded, 29 patients were treated with successful preservation of orbital contents. The CT angiography could efficiently determine all feeding arteries supplying the cancers. Consequently, chemotherapy could be administered on schedule, and side effects were minimal and acceptable.
This new method has promising applications in the treatment of advanced paranasal sinus carcinomas involving the skull base.
对于晚期鼻窦癌以及由颈内动脉(ICA)供血且累及颅底的残余癌,动脉内化疗最显著的问题是缺乏挽救性治疗方法。
本研究旨在评估包括颈内动脉灌注在内的动脉内化疗对治疗侵犯颅底的晚期鼻窦癌的有效性。
46例由颈内动脉供血的晚期鼻窦癌患者接受了动脉内化疗,使用顺铂(CDDP)和硫代硫酸钠(STS)作为CDDP毒性的中和剂。在评估CT血管造影后,每周向包括颈内动脉在内的每条供血动脉超选择性给予150mg/m²的CDDP,共4次。
10年总生存率和无进展生存率分别为70.7%和60.2%。与未灌注颈内动脉的对照组相比,前颅底或筛窦前部的复发明显减少。在32例眶尖受侵的患者中,29例患者成功保留了眶内容物。CT血管造影能够有效地确定所有为肿瘤供血的动脉。因此,化疗能够按时进行,且副作用极小且可接受。
这种新方法在治疗累及颅底的晚期鼻窦癌方面具有广阔的应用前景。